Global study shows how a country’s wealth affects SMA diagnosis rates
WHY IT MATTERS
If you live in a lower-income country, this research highlights why SMA diagnosis rates may be lower in your region and underscores the importance of advocating for expanded newborn screening and diagnostic access in your healthcare system.
A new global study found that spinal muscular atrophy (SMA) is diagnosed more often in wealthier countries. This is likely because richer countries have better access to the tools needed to find SMA, including newborn screening programs and modern treatments. The higher number of diagnosed cases in wealthy countries doesn't necessarily mean more people actually have SMA — it probably just means more people are being tested and diagnosed.
Spinal muscular atrophy (SMA) is more common in wealthier countries across the globe, likely reflecting increased access to diagnostic tools, newborn screening, and modern treatments. That higher prevalence — the total proportion of a population living with a specific condition at a given time — would normally suggest a greater overall disease burden of SMA […] The post Global study shows how a country’s wealth affects SMA diagnosis rates appeared first on SMA News Today .